Preliminary data from ongoing Phase 1/2 trials show BEAM-302 is well tolerated and achieves dose-dependent, durable ...

COVID-19 remains active in 2025, with new variants like LF.7 and NB.1.8.1 causing global spikes. India’s dominant strain is ...

Tens of thousands of patients could benefit from liquid biopsies, which give results up to two weeks faster than tissue ...

The new "liquid biopsy" test searches for tiny fragments of DNA that are shed by tumours into the bloodstream - it can ...

Researchers in the U.K. have overthrown the orthodox view that childhood cancers have a low mutation burden, opening up new ...

People with lung cancer will be offered a new blood test designed to speed up access to targeted treatments and avoid ...

Five-year-old Briggs regularly hits the trail at his favorite park with the help of his specialized three-wheel bike. "He absolutely adores it," his dad, Tim Alberts, said. Briggs was born with a gene ...

Announcing the rollout on the eve of the world’s largest cancer conference, which will take place in Chicago from Friday, NHS ...

Beam Therapeutics Inc. (Nasdaq: BEAM), a biotechnology company developing precision genetic medicines through base editing, today announced that the United States (U.S.) Food and Drug Administration ...

Ancient DNA reveals how Mayan civilisation collapsed Celebrities Are Stealing the Show in the Knicks’ Playoff Run The Stock Market Is Crushing an Old Wall Street Cliché Trump administration backtracks ...

Quickly see what your crops could fetch on the market with our regularly updated Roblox Grow a Garden value list with the ...

Scientists have documented the way a single gene in the bacterium that causes bubonic plague, Yersinia pestis, allowed it to survive hundreds of years by adjusting its virulence and the length of time ...